BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Megestrol Acetate

a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)

300+ PubMed studies analyzed · 70 RCTs · Evidence Score: 54

Research Domains

Megestrol Acetate has been studied across 21 research domains including 🔬 Oncology, 🧬 Hormones, 🫘 Kidney, 🔥 Metabolic, 💪 Strength & Power. The primary research focus is 🔬 Oncology with 56% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Megestrol Acetate, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Halcinonide
16 shared targets
Chlormadinone
18 shared targets
Levonorgestrel
18 shared targets
Norgestrel
18 shared targets
Medroxyprogesterone
21 shared targets
17
18 shared targets
Beclomethasone
15 shared targets
Ethynodiol
18 shared targets
Norethindrone
16 shared targets
Methyltestosterone
14 shared targets
Loading evidence profile...

This evidence profile for Megestrol Acetate is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.